A. 임상개발에 가장 적합한 복방(S)을 선택합니다. B. 인체의 안전성, 유효성 및 선택성을 평가하기 위해 I기, II기 및 III기 임상시험을 실시한다. C. 규제 부서의 승인을 받았다.
화학 원료를 구입해야하는 경우 요청 정보를 제출하여최신견적을받으십시오.
3-MERCAPTO-3-METHYL-BUTYRYL-TYR-PHE-VAL-ASN-CYS-PRO-D-ARG-GLY-NH2
N-(2-amino-6-(4-methoxyphenyl)pyrimidin-4-yl)methanesulfonamide
(2S)-cyclohexyl({[5-(2,6-dimethoxyphenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl]carbonyl}amino)ethanoic acid
tert-butyl (S)-3-((5-bromo-2-chloropyrimidin-4-yl)amino)piperidine-1-carboxylate
bis(benzonitrile)palladium(II) dichloride
C16H18N4O2
4-[(2-메톡시에톡시)메틸]벤조산
1,2,3,4-tetrakis-O-(3,4,5-trihydroxybenzoyl)-alpha-D-glucopyranose
C21H21BrN2O2
5-BROMO-2-[(4-클로로벤질)옥시]벤잘데하이드
3-{[(1S)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione
N-[4-(6-chloro-2-isopropylamino-pyrimidin-4-ylsulfamoyl)-phenyl]-acetamide
methyl (1α,3α,4β)-4-[(tert-butoxycarbonyl)amino]-3-hydroxycyclohexanecarboxylate
4-phenoxy-2-phenylquinazoline
1H-Indazole-3-carboxamide, N-(2-methylphenyl)-
퀴놀린-5-설포닐 클로라이드
1-cyclopropyl-3-(4-(5-(2,2-difluoropropyl)-6a-methyl-6-oxo-5,6,6a,7,9,10-hexahydro[1,4]oxazino[3,4-h]pteridin-2-yl)phenyl)urea
6-(2,6-DICHLOROPHENYL)-8-METHYL-2-METHYLSULFONYL-8H-PYRIDO[2,3-D]PYRIMIDIN-7-ONE
N-phenylsulfonyl-5-hydroxy-6-methoxy-1H-indole
(2S,3S), 2-[4-methoxybenzylsulfanyl], 3-tertiobutyloxycarbonylamino-hexane-dioic acid 1-allyl ester, 6-tertiobutyl ester
trifluoroacetic acid
2H- 시클로 펜타 [b] 푸란 -2- 카르보니 트릴, 5- (아세틸 옥시) 헥사 히드로-(9Cl)